Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • weibominingdata
    Junior Member
    • Aug 2011
    • 3

    #1

    Inconsistent results of cuffcompare, looking for help

    Hi all,

    I have two transcripts files, a.gtf and b.gtf and I use cuffcompare to compare them. More specifically, I treat one as the reference annotation by putting it after the -r option. The command I use looks like this

    cuffcompare -r a.gtf b.gtf

    The second time, I use b.gtf as the reference annotation using the following command

    cuffcompare -r b.gtf a.gtf

    And I compare the two cuffcmp.stats files generated by these two commands and I find inconsistent number of loci, exons, inrons, almost everything in these two files. For example, there are 35930 loci in b.gtf if it is treated as the reference annotation, but the number of loci will be 35932 if b.gtf is not used as a reference annotation. Detail information are listed below. Can anyone tell me what happened here or give me some suggestions where materials about this are available? I google a lot but do not find explanations. Many thanks.

    # Cuffcompare v1.0.3 | Command line was:
    #cuffcompare -r a.gtf b.gtf
    #

    #= Summary for dataset: b.gtf :
    # Query mRNAs : 89421 in 35932 loci (76334 multi-exon transcripts)
    # (13738 multi-transcript loci, ~2.5 transcripts per locus)
    # Reference mRNAs : 24299 in 17251 loci (24299 multi-exon)
    # Corresponding super-loci: 11479
    #--------------------| Sn | Sp | fSn | fSp
    Base level: 84.0 37.7 - -
    Exon level: 65.8 25.3 75.8 29.1
    Intron level: 92.5 43.0 96.4 44.8
    Intron chain level: 25.6 8.2 100.0 42.0
    Transcript level: 0.0 0.0 0.2 0.0
    Locus level: 32.6 15.6 60.6 29.1
    Missed exons: 3380/130250 ( 2.6%)
    Wrong exons: 160300/338929 ( 47.3%)
    Missed introns: 1358/111559 ( 1.2%)
    Wrong introns: 110851/240016 ( 46.2%)
    Missed loci: 531/17251 ( 3.1%)
    Wrong loci: 22853/35932 ( 63.6%)

    ---------------------------------------------------------

    # Cuffcompare v1.0.3 | Command line was:
    #cuffcompare -r b.gtf a.gtf
    #

    #= Summary for dataset: a.gtf :
    # Query mRNAs : 37750 in 30116 loci (24288 multi-exon transcripts)
    # (5474 multi-transcript loci, ~1.3 transcripts per locus)
    # Reference mRNAs : 91369 in 35930 loci (78396 multi-exon)
    # Corresponding super-loci: 12575
    #--------------------| Sn | Sp | fSn | fSp
    Base level: 41.0 65.0 - -
    Exon level: 25.0 59.6 28.9 68.8
    Intron level: 42.9 92.2 44.7 96.1
    Intron chain level: 8.0 26.0 26.7 86.2
    Transcript level: 0.0 0.0 0.1 0.1
    Locus level: 15.9 19.0 22.7 27.1
    Missed exons: 158434/342083 ( 46.3%)
    Wrong exons: 13453/143700 ( 9.4%)
    Missed introns: 111449/240016 ( 46.4%)
    Wrong introns: 1328/111559 ( 1.2%)
    Missed loci: 21690/35930 ( 60.4%)
    Wrong loci: 10553/30116 ( 35.0%)
  • weibominingdata
    Junior Member
    • Aug 2011
    • 3

    #2
    Could someone answer my question? Please

    Comment

    • songyj
      Member
      • Sep 2011
      • 15

      #3
      I also confused about cuffcmp.stats

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:22 PM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      16 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      50 views
      0 reactions
      Last Post SEQadmin2  
      Working...